Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bissonnette

Showing results (171-180 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Investigative Dermatology|May 7, 2019
Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy IndividualsEster Del Duca, Ana B Pavel, Celina Dubin, et al.
Lancet (London, England)|July 21, 2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trialsRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
American Journal of Clinical Dermatology|May 3, 2022
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Mette Deleuran, Robert Bissonnette, et al.
Lancet (London, England)|April 12, 2025
Reflections on chronic hand eczema - Authors' replyRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2025
Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Robert Bissonnette, et al.
The British Journal of Dermatology|April 19, 2023
The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activityA David Burden, Hervé Bachelez, Siew Eng Choon, et al.
Allergy|August 14, 2023
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsiesEster Del Duca, Helen He, Ying Liu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trialTali Czarnowicki, Anders B Dohlman, Kunal Malik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 8, 2025
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigoLea S Stahl, Claudia Zeidler, Joyce Loewenthal, et al.
Drug Safety|June 2, 2021
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLARRobert Bissonnette, Alice B Gottlieb, Richard G Langley, et al.
Pageof 23

Showing results (171-180 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Investigative Dermatology|May 7, 2019
Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy IndividualsEster Del Duca, Ana B Pavel, Celina Dubin, et al.
Lancet (London, England)|July 21, 2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trialsRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
American Journal of Clinical Dermatology|May 3, 2022
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Mette Deleuran, Robert Bissonnette, et al.
Lancet (London, England)|April 12, 2025
Reflections on chronic hand eczema - Authors' replyRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2025
Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Robert Bissonnette, et al.
The British Journal of Dermatology|April 19, 2023
The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activityA David Burden, Hervé Bachelez, Siew Eng Choon, et al.
Allergy|August 14, 2023
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsiesEster Del Duca, Helen He, Ying Liu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trialTali Czarnowicki, Anders B Dohlman, Kunal Malik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 8, 2025
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigoLea S Stahl, Claudia Zeidler, Joyce Loewenthal, et al.
Drug Safety|June 2, 2021
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLARRobert Bissonnette, Alice B Gottlieb, Richard G Langley, et al.
Pageof 23